Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
22 August 2022 |
Main ID: |
NCT03738150 |
Date of registration:
|
02/11/2018 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
A Study of Sotatercept for the Treatment of Pulmonary Arterial Hypertension
SPECTRA |
Scientific title:
|
A Phase 2a Single-Arm, Open-Label, Multicenter Exploratory Study to Assess the Effects of Sotatercept (ACE-011) for the Treatment of Pulmonary Arterial Hypertension |
Date of first enrolment:
|
April 19, 2019 |
Target sample size:
|
21 |
Recruitment status: |
Completed |
URL:
|
https://clinicaltrials.gov/show/NCT03738150 |
Study type:
|
Interventional |
Study design:
|
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
Phase:
|
Phase 2
|
|
Countries of recruitment
|
United States
| | | | | | | |
Contacts
|
Name:
|
Medical Director |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Merck Sharp & Dohme LLC |
| | |
Key inclusion & exclusion criteria
|
Health Condition(s) or Problem(s) studied
|
Source(s) of Monetary Support
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|